These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23181278)

  • 1. Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats.
    Wang HM; Wang Y; Liu M; Bai Y; Zhang XH; Sun YX; Wang HL
    Can J Physiol Pharmacol; 2012 Nov; 90(11):1506-15. PubMed ID: 23181278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats.
    Zhai FG; Zhang XH; Wang HL
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):850-6. PubMed ID: 19298536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
    Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
    Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Han DD; Wang Y; Zhang XH; Liu JR; Wang HL
    Can J Physiol Pharmacol; 2012 Apr; 90(4):445-54. PubMed ID: 22448962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous fluoxetine administration prevents recurrence of pulmonary arterial hypertension and prolongs survival in rats.
    Zhu SP; Mao ZF; Huang J; Wang JY
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):e1-5. PubMed ID: 19473340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
    Wu F; Yao W; Yang J; Zhang M; Xu Y; Hao Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
    Biomed Pharmacother; 2017 Nov; 95():1161-1168. PubMed ID: 28926926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KMUP-1 inhibits pulmonary artery proliferation by targeting serotonin receptors/transporter and NO synthase, inactivating RhoA and suppressing AKT/ERK phosphorylation.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Vascul Pharmacol; 2010; 53(5-6):239-49. PubMed ID: 20870034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
    Wang Y; Zhang XH; Wang HL
    Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats.
    Li XQ; Wang HM; Yang CG; Zhang XH; Han DD; Wang HL
    Acta Pharmacol Sin; 2011 Feb; 32(2):217-22. PubMed ID: 21217769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone.
    Homma N; Nagaoka T; Karoor V; Imamura M; Taraseviciene-Stewart L; Walker LA; Fagan KA; McMurtry IF; Oka M
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L71-8. PubMed ID: 18469113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of S100A4/Mts1 and associated proteins in the protective effect of fluoxetine against MCT - Induced pulmonary hypertension in rats.
    Song ZH; Wang HM; Liu M; Bai Y; Wang Y; Wang HL
    J Chin Med Assoc; 2018 Dec; 81(12):1077-1087. PubMed ID: 30031694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
    Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
    Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
    Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
    Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of osteopontin is associated with fluoxetine amelioration of monocrotaline-induced pulmonary inflammation and vascular remodelling.
    Wang Y; Han DD; Wang HM; Liu M; Zhang XH; Wang HL
    Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):365-72. PubMed ID: 21418086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension.
    Houssaini A; Abid S; Mouraret N; Wan F; Rideau D; Saker M; Marcos E; Tissot CM; Dubois-Randé JL; Amsellem V; Adnot S
    Am J Respir Cell Mol Biol; 2013 May; 48(5):568-77. PubMed ID: 23470622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and activity of RhoA/Rho kinase in remodeling of high blood flow pulmonary vessels.].
    Li FH; Xia W; Sun RP
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):387-92. PubMed ID: 17697629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic administration of serotonin transporter inhibitor (fluoxetine) decreases monocrotaline-induced pulmonary hypertension in rats].
    Kozhevnikova VV; Medvedeva NA
    Eksp Klin Farmakol; 2007; 70(5):15-8. PubMed ID: 18074800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.